Search
Close this search box.
CHDI Conference Session IV - Drs. Jim Rosinski and Aline Delva

CHDI Conference Session IV - Drs. Jim Rosinski and Aline Delva

Jim Rosinski Jim Rosinski from the CHDI Foundation spoke about the -omics strategy at CHDI Foundation to identify early biomarkers of disease progression, with a focus today on the early analysis of the CSF and plasma samples derived from the HD Clarity study using the Somalogics platform. The goal of…
Latest article from our founder on mutant HTT imaging

Latest article from our founder on mutant HTT imaging

Revealing mHTT in real-time Huntington’s disease (HD) is caused by mutations in the gene encoding for the protein huntingtin (HTT), leading to accumulation of toxic mutant HTT (mHTT) aggregates. Development of therapies aiming to reduce mHTT is hindered by the lack of imaging methods to visualize mHTT in the living…
EN